LOXL1 and glioblastoma: Through analyzing patients’ clinical information and genetic profiles from online databases, TIMP1, ITGA5, FCGR2B, UPP1, ISG20, TSPAN4, and LOXL1 were identified as potential prognostic biomarkers for glioblastoma.